In the present work, we focused on BECN1, a tumor suppressor gene that positively regulates autophagy, and tested its prognostic value, either alone or in combination with BCL2, as a marker for DLBCL patient risk stratification. Here, BECN1 is linked to diffuse large B-cell lymphoma.